Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119445709 | 11944570 | 9 | F | 2014 | 20160817 | 20160125 | 20160819 | EXP | PHHY2014LB068641 | NOVARTIS | 25.79 | YR | M | Y | 79.00000 | KG | 20160819 | CN | COUNTRY NOT SPECIFIED | LB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119445709 | 11944570 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | U | 22068 | 600 | MG | CAPSULE | QD | |||||
| 119445709 | 11944570 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | U | 22068 | 600 | MG | CAPSULE | QD | |||||
| 119445709 | 11944570 | 3 | SS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD (300 MG AT MORNING AND 300 MG AT EVENING) | U | 22068 | 600 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119445709 | 11944570 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119445709 | 11944570 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119445709 | 11944570 | Cytogenetic analysis abnormal | |
| 119445709 | 11944570 | Depression | |
| 119445709 | 11944570 | Dizziness | |
| 119445709 | 11944570 | Fatigue | |
| 119445709 | 11944570 | Flank pain | |
| 119445709 | 11944570 | Hypersensitivity | |
| 119445709 | 11944570 | Hypersomnia | |
| 119445709 | 11944570 | Increased appetite | |
| 119445709 | 11944570 | Influenza | |
| 119445709 | 11944570 | Nausea | |
| 119445709 | 11944570 | Nephrolithiasis | |
| 119445709 | 11944570 | Paraesthesia | |
| 119445709 | 11944570 | Pyrexia | |
| 119445709 | 11944570 | Sneezing | |
| 119445709 | 11944570 | Tachycardia | |
| 119445709 | 11944570 | Vision blurred | |
| 119445709 | 11944570 | Vomiting | |
| 119445709 | 11944570 | Weight decreased | |
| 119445709 | 11944570 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119445709 | 11944570 | 1 | 201404 | 201511 | 0 | |
| 119445709 | 11944570 | 2 | 201602 | 0 |